Holen Sie sich die Stockscreener-App
8.52
2.77%
0.23
Schlusskurs vom Vortag:
$8.29
Offen:
$8.2
24-Stunden-Volumen:
22,862
Relative Volume:
0.14
Marktkapitalisierung:
$160.48M
Einnahmen:
$107.35M
Nettoeinkommen (Verlust:
$6.84M
KGV:
24.12
EPS:
0.3532
Netto-Cashflow:
$14.64M
1W Leistung:
+1.67%
1M Leistung:
+12.70%
6M Leistung:
+33.12%
1J Leistung:
-58.21%
1-Tages-Spanne:
$8.11
$8.52
1-Wochen-Bereich:
$8.14
$8.59
52-Wochen-Spanne:
$4.54
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, TEM, BTSG, HNGE, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
8.52 | 160.48M | 107.35M | 6.84M | 14.64M | 0.3532 |
VEEV
Veeva Systems Inc
|
311.57 | 50.45B | 3.32B | 941.65M | 1.64B | 5.6161 |
TEM
Tempus Ai Inc
|
70.02 | 12.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
BTSG
Brightspring Health Services Inc
|
62.86 | 12.44B | 13.65B | 169.86M | 412.12M | 1.0758 |
HNGE
Hinge Health Inc
|
104.99 | 8.47B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
92.58 | 7.66B | 1.34B | 230.70M | 440.96M | 2.6695 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-29 | Fortgesetzt | B. Riley Securities | Buy |
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-11-01 | Eingeleitet | Stifel | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com Canada
Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com UK
Stock vesting triggers tax withholding at OptimizeRx (OPRX): 414 shares at $8.39 each. - Stock Titan
Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars? - Zacks Investment Research
Optimizerx stock edges lower as investors digest recent results - AD HOC NEWS
OptimizeRx stock gains guidance clarity after Q2 2026 results - AD HOC NEWS
OPRX 8-K FilingsOptimizeRx Corporation SEC 8-K - Stock Titan
OptimizeRx CorporationCommon Stock (Nasdaq:OPRX) Detailed Stock Data - The Chronicle-Journal
OPTIMIZERx Corp (NASDAQ: OPRX) Share Price, OPRX Stock News, OPRX Share Price & Updates - kalkine.com.au
One prompt now builds patient and doctor audiences. OptimizeRx expanded the tool. - Stock Titan
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference - marketscreener.com
A 10th annual growth conference is set for New York, with OptimizeRx taking part. - Stock Titan
OPTIMIZERx Corp (NASDAQ: OPRX) Share Price, OPRX Stock News, OPRX Share Price & Updates - kalkine.ca
OptimizeRx (OPRX) insider stock withheld for taxes - Stock Titan
OptimizeRx appoints Troy Sarich as company advisor By Investing.com - Investing.com Canada
OptimizeRx appoints Troy Sarich as company advisor - investing.com
OptimizeRx Appoints Former Johnson & Johnson Executive Troy Sarich as Company Advisor - Quiver Quantitative
OptimizeRx appoints Troy Sarich as company advisor By Investing.com - Investing.com UK
OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor - Yahoo Finance UK
OptimizeRx Corp. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com
OptimizeRx (NASDAQ: OPRX) COO keeps 25,187 shares after RSU tax withholding - Stock Titan
OptimizeRx (OPRX) records insider share trade - Stock Titan
OptimizeRx (NASDAQ: OPRX) insider logs new stock trade - Stock Titan
OptimizeRx (NASDAQ: OPRX) reports new insider share transaction - stocktitan.net
OPRX | OptimizeRx Corporation Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript - AOL.com
OptimizeRx (OPRX) EPS and Revenue: Profit Per Share Clears Its Benchmark in the Current Update; Closing Move - vinanet.vn
OptimizeRx Corp (OPRX) Stock News Today - TradingKey
OptimizeRx Corp (OPRX) Stock News Today - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
OptimizeRx (OPRX) Slips to $8.72 as Shares Consolidate Near Range MidpointInverse ETF Flow - vinanet.vn
Optimizerx Stock Price Forecast. Should You Buy OPRX? - StockInvest.us
OptimizeRx Corp (OPRX) gains 6.7% institutional holder in Kennedy Capital - Stock Titan
Conferencia de resultados del segundo trimestre fiscal de 2026 de OptimizeRx (OPRX): Reitera previsiones mientras los ingresos caen un 30% - TradingKey
OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says - marketbeat.com
Citizens raises OptimizeRx stock price target on macro stability By Investing.com - Investing.com Nigeria
Citizens raises OptimizeRx stock price target on macro stability By Investing.com - Investing.com South Africa
Citizens raises OptimizeRx stock price target on macro stability - Investing.com
Citizens raises OptimizeRx stock price target on macro stability By Investing.com - Investing.com Canada
Citizens raises OptimizeRx stock price target on macro stability By Investing.com - Investing.com India
Citizens raises OptimizeRx stock price target on macro stability - Investing.com
Renaissance Technologies LLC Has $1.36 Million Stock Position in OptimizeRx Corp. $OPRX - MarketBeat
OptimizeRx (OPRX) Earnings Call zu Q2 des Geschäftsjahres 2026: Prognose bestätigt, während der Umsatz um 30 % sinkt - TradingKey
OptimizeRx (OPRX) Fiscal Q2 2026 Earnings Call: Guidance Reaffirmed as Revenue Falls 30% - TradingKey
Stifel cuts OptimizeRx stock price target on revenue headwinds By Investing.com - Investing.com Australia
OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline - The Globe and Mail
OptimizeRx (OPRX) revenue falls 21% as margins and cash flow hold - Stock Titan
Stifel cuts OptimizeRx stock price target on revenue headwinds By Investing.com - Investing.com Australia
Stifel cuts OptimizeRx stock price target on revenue headwinds - Investing.com
Stifel cuts OptimizeRx stock price target on revenue headwinds By Investing.com - Investing.com Nigeria
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Optimizerx Corp-Aktie (OPRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Odence-Ford Marion | Chief Legal & Admin Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
3,928 |
0 |
94,526 |
| Besch Doug | Chief Product & Tech Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
1,964 |
0 |
71,536 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Dec 19 '25 |
Sale |
13.51 |
1,388 |
18,752 |
126,830 |
| Silvestro Stephen L | Chief Executive Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
6,546 |
0 |
195,462 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
92,550 |
2.59%
2.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):